Outcome of patients in CCyR and not in CCyR at specific time points during imatinib therapy
Months on treatment . | No. (%) in CCyR . | No. (%) not in CCyR . | Percentage eventually achieving outcome if not in CCyR at specified time . | ||
---|---|---|---|---|---|
CCyR . | MMR . | Event . | |||
3 | 143 (56) | 109 (43) | 75 | 62 | 23 |
6 | 190 (79) | 47 (20) | 57 | 43 | 34 |
12 | 200 (85) | 26 (12) | 42 | 31 | 38 |
P | .002 | .004 | .16 |
Months on treatment . | No. (%) in CCyR . | No. (%) not in CCyR . | Percentage eventually achieving outcome if not in CCyR at specified time . | ||
---|---|---|---|---|---|
CCyR . | MMR . | Event . | |||
3 | 143 (56) | 109 (43) | 75 | 62 | 23 |
6 | 190 (79) | 47 (20) | 57 | 43 | 34 |
12 | 200 (85) | 26 (12) | 42 | 31 | 38 |
P | .002 | .004 | .16 |